The ability to design proteins with high affinity and selectivity for any given small molecule is a rigorous test of our understanding of the physiochemical principles that govern molecular recognition. Attempts to rationally design ligand-binding proteins have met with little success, however, and the computational design of proteinsmall-molecule interfaces remains an unsolved problem 1 . Current approaches for designing ligand-binding proteins for medical 2 and biotechnological uses rely on raising antibodies against a target antigen in immunized animals 3, 4 and/or performing laboratorydirected evolution of proteins with an existing low affinity for the desired ligand [5] [6] [7] , neither of which allows complete control over the interactions involved in binding. Here we describe a general computational method for designing pre-organized and shape complementary small-molecule-binding sites, and use it to generate protein binders to the steroid digoxigenin (DIG). Of seventeen experimentally characterized designs, two bind DIG; the model of the higher affinity binder has the most energetically favourable and pre-organized interface in the design set. A comprehensive binding-fitness landscape of this design, generated by library selections and deep sequencing, was used to optimize its binding affinity to a picomolar level, and X-ray co-crystal structures of two variants show atomic-level agreement with the corresponding computational models. The optimized binder is selective for DIG over the related steroids digitoxigenin, progesterone and b-oestradiol, and this steroid binding preference can be reprogrammed by manipulation of explicitly designed hydrogen-bonding interactions. The computational design method presented here should enable the development of a new generation of biosensors, therapeutics and diagnostics.
. The lack of accuracy in programming protein-small-molecule interactions also contributes to low catalytic efficiencies of computationally designed enzymes [9] [10] [11] [12] [13] [14] . The development of robust computational methods for the design of small-molecule-binding proteins with high affinity and selectivity would have wide-ranging applications.
We developed a computational method for designing ligand-binding proteins with three properties characteristic of naturally occurring binding sites: (1) specific energetically favourable hydrogen-bonding and van der Waals interactions with the ligand; (2) high overall shape complementarity to the ligand; and (3) structural pre-organization in the unbound protein state, which minimizes entropy loss upon ligand binding 15, 16 . To program in defined interactions with the small molecule, disembodied binding sites are created by positioning amino acid side chains around the ligand in optimal orientations and then placed at geometrically compatible sites in a set of scaffold protein structures 17 . The surrounding side chain identities and conformations are then optimized to generate additional protein-ligand and buttressing proteinprotein interactions (Fig. 1a) . Designs with protein-small-molecule shape complementarity below those typical of native complexes 18 or having interface side chain conformations with low Boltzmann-weighted probabilities in the unbound state 16 are then discarded. We used the method to design proteins that bind the steroid DIG ( Supplementary Fig. 1 ), the aglycone of digoxin, a cardiac glycoside used to treat heart disease 19 and a non-radioactive biomolecular labelling reagent 20 . Anti-digoxigenin antibodies are administered to treat overdoses of digoxin, which has a narrow therapeutic window 21 , and are used to detect biomolecules in applications such as fluorescence in situ hybridization 20 . We created idealized DIG-binding sites featuring hydrogen bonds from Tyr or His to the polar groups of DIG and hydrophobic packing interactions between Tyr, Phe or Trp and the steroid ring system (Fig. 1a) . These interactions were embedded in designed binding sites with high shape complementarity to DIG, and 17 designs were selected for experimental characterization based on computed binding affinity, shape complementarity, and the extent of binding site preorganization in the unbound state (Fig. 1b and Supplementary Tables  1 and 2) .
Binding of the designed proteins to DIG was probed by yeast surface display 22 and flow cytometry using DIG-functionalized bovine serum albumin (DIG-BSA) or RNase (DIG-RNase). Designed proteins DIG5 and DIG10 bound to both labels ( Fig. 1c and Supplementary  Fig. 2 ), and binding was reduced to background levels when unlabelled DIG was added as a competitor ( Fig. 1c and Supplementary Fig. 3 ). Fluorescence polarization measurements with purified proteins and Alexa488-fluorophore-conjugated DIG (DIG-PEG 3 -Alexa488) indicated affinities in the low-to-mid micromolar range, with DIG10 binding more tightly (Fig. 2a, b) . Isothermal titration calorimetry (ITC) measurements confirmed that the affinity of DIG10 for DIG is identical to that for DIG-PEG 3 -Alexa488 (Fig. 2b, Supplementary Fig. 4 and Supplementary Table 3 ). The scaffold from which both DIG5 and DIG10 derive, a protein of unknown function from Pseudomonas aeruginosa (Protein Data Bank (PDB) accession code 1Z1S), does not bind to either label ( Fig. 1c and Supplementary Fig. 3a ) when expressed on the yeast surface or to DIG-PEG 3 -Alexa488 in solution (Fig. 2a) , suggesting that the binding activities of both proteins are mediated by the computationally designed interfaces. Indeed, substitution of small nonpolar residues in the binding pockets of DIG5 and DIG10 with arginines resulted in complete loss of binding, and mutation of the designed hydrogen-bonding tyrosine and histidine residues to phenylalanine reduced (DIG5) or abolished (DIG10) binding ( Fig. 1d and Supplementary Fig. 5 ). Optimization of DIG10 by site-saturation mutagenesis and selections using yeast surface display and fluorescenceactivated cell sorting (FACS) identified several small-to-large hydrophobic amino acid changes that increase binding affinity 75-fold through enhanced binding enthalpy, yielding DIG10.1 (Fig. 2b, c, Table 3) .
To provide feedback for improving the overall design methodology and to evaluate the contribution of each residue in the DIG10.1-binding site, we used next-generation sequencing to generate a comprehensive binding fitness map [23] [24] [25] . A library of variants with approximately 1-3 substitutions at 39 designed interface positions in DIG10.1 was generated using doped oligonucleotide mutagenesis, displayed on yeast, and subjected to selections using a monovalent DIG-PEG 3 -biotin conjugate ( Supplementary Fig. 9 ). Variants with increased affinity for DIG were selected by FACS, and next-generation sequencing was used to quantify the frequency of every single point mutation in the unselected and selected populations. A large majority of the interrogated variants were depleted in the selected population relative to the unselected input library, suggesting that most of the DIG10.1-binding site residues are optimal for binding (Fig. 2d, e and Supplementary Fig. 10 ). In particular, mutation of the three designed hydrogen-bonding residues, Tyr 34, Tyr 101 and Tyr 115, to any other amino acid was disfavoured. Several large hydrophobic residues that pack against the ligand in the computational model are also functionally optimal (for example, Phe 66 and Phe 119). Besides Ala 99, which contacts DIG directly, most of the observed mutations that improve binding are located in the second coordination shell of the ligand and fall into two categories: (1) protein core substitutions tolerating mutation to chemically similar amino acids (for example, Leu 105 and Cys 23), and (2) solvent-exposed loop residues having high sequence entropy (for example, His 90 and Val 92). The best clone obtained from sorting the library to homogeneity, DIG10.2, contains two of the most highly enriched mutations, Ala37Pro and His41Tyr (Fig. 2b, c and Supplementary Figs 4, 6, 8 and 11) .
To increase binding affinity further, we constructed a library in which the residues at 11 positions that acquired beneficial substitutions in the deep sequencing experiment were varied in combination to allow for non-additive effects. Selections led to DIG10.3 (Supplementary Figs 4, 6, 8 and 12) , which binds DIG and its cardiac glycoside derivative digoxin with picomolar affinity (Fig. 2b, Supplementary  Fig. 13 and Supplementary Table 4) , rivalling the affinities of antidigoxin antibody therapeutics 21 and an evolved single-chain variable anti-digoxin antibody fragment 7 . Fluorescence-polarization-based affinity measurements of DIG10.3 and Tyr knockouts suggest that the designed hydrogen bonds each contribute ,2 kcal mol 21 to binding energy (Supplementary Table 5 and Supplementary Fig. 8 ).
The crystal structures of DIG10.2 and DIG10.3 in complex with DIG were solved to 2.05 Å and 3.2 Å resolution, respectively (Fig. 3a, b and We assessed the binding specificity of DIG10.3 by determining affinities for a series of related steroids by equilibrium competition fluorescence polarization. Digitoxigenin, progesterone and b-oestradiol bind less tightly to DIG10.3 than DIG (Fig. 4a, b and Supplementary Table 4 ). The magnitudes of the affinity decreases are consistent with the loss of one, two and three hydrogen bonds, respectively (assuming ,1.8 kcal mol -1 per hydrogen bond 26 ), suggesting that these compounds bind in the same orientation as DIG. We next investigated whether the observed steroid selectivity could be reprogrammed by mutagenesis of the key hydrogenbonding tyrosines. The variants Tyr101Phe, Tyr34Phe and Tyr34Phe/ Tyr99Phe/Tyr101Phe show clear preferences for more hydrophobic steroids in a predictable manner that depends on the hydrogen-bonding capabilities of both the protein and the steroid. Tyr101Phe eliminates the DIG-specific hydrogen bond with DIG O2 and provides a more hydrophobic environment that favours the other three steroids (Fig. 4c ). Tyr34Phe removes a hydrogen bond common to DIG and digitoxigenin, thus enhancing the preference for progesterone (Fig. 4d) . Tyr34Phe/ Tyr99Phe/Tyr101Phe has decreased affinity for DIG and increased affinity for the more hydrophobic steroids (Fig. 4e) . These results confirm that the selectivity of DIG10.3 for DIG is conferred through the designed hydrogen-bonding interactions and demonstrate how this feature can be programmed using positive design alone through the explicit placement of designed polar and hydrophobic interactions.
Comparison of the properties of successful and unsuccessful designs provides a test of the hypotheses underlying the design methodology. Although all 17 designed proteins had high computed shape complementarity to DIG by construction, the DIG10 design, which had the highest affinity for DIG, had the most favourable computed proteinligand interaction energy and was predicted to have the most preorganized binding site (Fig. 1b and Supplementary Table 6 ), suggesting that these attributes should continue to be the focus of future design methodology development. One potential avenue for obtaining more favourable interaction energies would be incorporating backbone flexibility during design to achieve more tightly packed binding sites: the fact that substitution of small hydrophobic interface residues to larger ones increased binding affinity indicates that the original DIG10 design was under-packed.
The binding fitness landscape in combination with the X-ray cocrystal structures highlight the importance of second shell interactions 
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in stabilizing binding competent conformations. For example, the enriched substitution Leu105Trp (Fig. 2d) causes the adjacent Tyr 115 side chain, which shows conformational variability in DIG10.2, to adopt a single conformation in DIG10.3 that makes a more canonical hydrogen bond to DIG than that of the DIG10.2 alternative state ( Fig. 3e and Supplementary Fig. 19 ). The calculated side chain pre-organization of all three hydrogen-bonding tyrosine residues increases from DIG10.2 to DIG10.3 (Supplementary Table 7 ), suggesting that the increased affinity may arise in part from a higher proportion of the binding competent conformation of apo-DIG10. 3 (refs 15, 27) . Indeed, ITC studies confirm that entropic as well as enthalpic factors contribute to the enhanced binding affinity of DIG10.3 ( Fig. 2f and Supplementary Table 3) . Similarly, reduced backbone conformational entropy is probably responsible for the increased fitness of substitutions increasing b-sheet propensity at inter-strand loop positions 90 and 92 (Fig. 2d) . That flexibility is selected against during affinity maturation suggests that maximizing the freeenergy gap between binding-competent and alternative states of the binding site 28 by explicitly designing second shell interactions to buttress side chains making key ligand contacts should help to achieve high affinity in the next generation of computationally designed ligand-binding proteins. The binding affinity of DIG10.3 is similar to those of anti-digoxin antibodies 21 , and because it is stable for extended periods (.3 months) at ambient temperatures ( Supplementary Fig. 20 ) and can be expressed at high levels in bacteria, it could provide a more cost-effective alternative for biotechnological and for therapeutic purposes if it can be made compatible with the human immune response. With continued improvement in the methodology and feedback from experimental results, computational protein design should provide an increasingly powerful approach to creating small molecule receptors for synthetic biology, therapeutic scavengers for toxic compounds, and robust binding domains for diagnostic devices.
METHODS SUMMARY
Design calculations were performed using RosettaMatch 17 to incorporate five predefined interactions to DIG into a set of 401 scaffolds. RosettaDesign 29 was then 
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used to optimize each binding site sequence for maximal ligand-binding affinity. Designs having low interface energy, high shape complementarity, and high binding site pre-organization were selected for experimental characterization. Example command lines and full design protocols are given in the Supplementary Data. Designs were displayed on the surface of yeast strain EBY100 and examined for binding to a mixture of 2.7 mM biotinylated DIG-conjugated BSA or DIG-conjugated RNase and streptavidin-phycoerythrin on an Accuri C6 flow cytometer. Binding clones from yeast-surface displayed libraries based on DIG10 were selected using highly avid DIG-BSA or DIG-RNase or monovalent DIG-conjugated biotin on a Cytopeia inFlux cell sorter. DIG10.1-derived library DNA was sequenced in pairedend mode on an Illumina MiSeq. For single mutations having $7 counts in the original input library, a relative enrichment ratio between the input library and each selected library was calculated [23] [24] [25] . The effect of each amino acid substitution on binding, DE x i , was computed with equation (1), For biochemical assays, proteins were expressed in E. coli Rosetta 2 (DE3) cells with a carboxy-terminal tobacco etch virus (TEV) protease-cleavable His 6 tag. For crystallographic analysis of DIG10 variants, a 12-amino-acid structurally disordered C terminus deriving from the scaffold protein 1Z1S was replaced directly with a His 6 tag. Binding affinities were determined by equilibrium fluorescence polarization 30 on a SpectraMax M5e microplate reader by monitoring the anisotropy of DIG-conjugated Alexa488 as a function of protein concentration. Equilibrium fluorescence polarization competition assays were performed by examining the effect of increasing concentrations of unlabelled DIG, digitoxigenin, progesterone and b-oestradiol on the anisotropy of designed protein2DIG-conjugated Alexa488 complex. ITC studies were performed on an iTC200 microcalorimeter.
Full Methods and any associated references are available in the online version of the paper.
METHODS
General methods. Full details for all computational and experimental methods are given in Supplementary Methods. Design calculations were performed using RosettaDesign 29 . Dissociation constants (K d values) of designs were determined by equilibrium fluorescence polarization 30 and by ITC. Example command lines and RosettaScripts 31 design protocols are provided in Supplementary Data. Source code is freely available to academic users through the Rosetta Commons agreement (http://www.rosettacommons.org/). Design models, the scaffold library, and scripts for running design calculations are provided on the Baker laboratory website. Matching. RosettaMatch 17 was used to identify backbone constellations in 401 protein scaffold structures where a DIG molecule and side chain conformations interacting with DIG in a pre-defined geometry could be accommodated. This set contained scaffolds previously used for design projects within our laboratory 10, 13, 32 , as well as structural homologues of a subset of these scaffolds that are known to tolerate mutations. Full details are given in Supplementary Methods. Rosetta sequence design. Two successive rounds of sequence design were used. The purpose of the first was to maximize binding affinity for the ligand 33 . The goal of the second was to minimize protein destabilization due to aggressive scaffold mutagenesis while maintaining the binding interface designed during the first round. During the latter round, ligand-protein interactions were up-weighted by a factor of 1.5 relative to intra-protein interactions to ensure that binding energy was preserved. Two different criteria were used to minimize protein destabilization: (1) native scaffold residues identities were favoured by 1.5 REU, and (2) no more than five residues were allowed to change from residue types observed in a multiple sequence alignment (MSA) of the scaffold if (a) these residues were present in the MSA with a frequency greater than 0.6, or (b) if the calculated DDG for mutation of the scaffold residue to alanine 34 was greater than 1.5 REU in the context of the scaffold sequence. In some design calculations, identities of the matched hydrogen-bonding residues were allowed to vary according to the MSA and DDG criteria described above. In these cases, designs having fewer than three hydrogen bonds between the protein and the ligand were discarded. Design evaluation. Designs were evaluated on interface energy, ligand solvent exposed surface area, ligand orientation, shape complementarity, and apo-protein binding site pre-organization. The latter was enforced by explicitly introducing second-shell amino acids that bolster the programmed interacting residues using Foldit 35 and by selecting designs having rotamer Boltzmann probabilities 16 . 0.1 for at least one hydrogen-bonding residue (Supplementary Table 6 ). High shape complementarity was enforced by rejecting designs having S c , 0.5. Shape complimentary was computed using the CCP4 package v.6.0.2 (ref. 36) using the S c program 18 and the Rosetta radii library. All designs were evaluated for local sequence secondary structure compatibility, and those predicted to have backbone conformations that varied by .0.8 Å from their native scaffold were rejected (see Supplementary Methods). General experimental methods. Detailed procedures for the syntheses of DIG-BSA-biotin, DIG-RNase-biotin, DIG-PEG 3 -biotin, and DIG-PEG 3 -Alexa488, as well as protein expression, purification, crystallization, cloning and mutagenesis methods are given in Supplementary Methods. Details about fluorescence polarization binding assays, ITC, gel filtration analysis, analytical ultracentrifugation experiments, and circular dichroism protein stability measurements are also provided in Supplementary Methods. Yeast surface display. Designed proteins were tested for binding using yeastsurface display 22 . Yeast surface protein expression was monitored by binding of anti-c-Myc-FITC to the C-terminal Myc epitope tag of the displayed protein. DIG binding was assessed by quantifying the phycoerythrin (PE) fluorescence of the displaying yeast population following incubation with DIG-BSA-biotin, DIGRNase-biotin, or DIG-PEG 3 -biotin, and streptavidin-phycoerythrin (SAPE). In a typical experiment using DIG-BSA-biotin or DIG-RNase-biotin, cells were resuspended in a premixed solution of PBSF (PBS plus 1 g L 21 of BSA) containing a 1:100 dilution of anti-c-Myc-FITC, 2.66 mM DIG-BSA-biotin or DIG-RNasebiotin, and 664 nM SAPE for 2-4 h at 4 uC. Cellular fluorescence was monitored on an Accuri C6 flow cytometer using a 488-nm laser for excitation and a 575-nm bandpass filter for emission. Phycoerythrin fluorescence was compensated to minimize bleed-over contributions from the FITC channel. Competition assays with free DIG were performed as above except that between 750 mM and 1.5 mM DIG was added to each labelling reaction mixture. Full details are given in Supplementary Methods. Affinity maturation. Detailed procedures for constructing and selecting all libraries, including those for deep sequencing, are provided in Supplementary Methods. Yeast surface display library selections were conducted on a Cytopeia inFlux cell sorter using increasingly stringent conditions. In all labelling reactions for selections, care was taken to maintain at least a tenfold molar excess of label to cell surface protein. Cell surface protein molarity was estimated by assuming that an attenuance at 600 nm (D 600 nm ) of 1.0 5 1 3 10 7 cells ml 21 , and that each cell displays 50,000 copies of protein 22 . For each round of sorting, we sorted at least 10 times the theoretical library size. FlowJo software v. 7.6 was used to analyse all data. Cell sorting parameters and statistics for all selections are given in Supplementary  Table 9 . Next-generation sequencing. Two sequencing libraries based on DIG10.1 were assembled by recursive PCR: an amino-terminal library (fragment 1 library) and a carboxy-terminal library (fragment 2 library). To introduce mutations, we used degenerate PAGE-purified oligonucleotides in which the bases coding for 39 selected binding site amino acid residues were doped with a small amount of each non-native base at a level expected to yield 1-2 mutations per gene (TriLink BioTechnologies) (Supplementary Table 10 ). Yeast cells were transformed with DNA insert and restriction-digested pETCON 37 . Surface protein expression was induced 22 and cells were labelled with anti-c-Myc-FITC and sorted for protein expression. Expressing cells were recovered, induced, labelled with 100 nM of DIG-PEG 3 -biotin for .3 h at 4 uC and then SAPE and anti-c-Myc-FITC for 8 min at 4 uC, and then sorted. For each library, clones having binding signals higher than that of DIG10.1 were collected (Supplementary Fig. 9 ). To reduce noise from the first round of cell sorting, the sorted libraries were recovered, induced, and subjected to a second round of sorting using the same conditions (see Supplementary Methods).
Library DNA was prepared as described 25 . Illumina adaptor sequences and unique library barcodes were appended to each library pool by PCR amplification using population-specific primers (Supplementary Table 11 ). DNA was sequenced in paired-end mode on an Illumina MiSeq using a 300-cycle reagent kit and custom primers (see Supplementary Methods). Of a total of 5,630,105 paired-end reads, 2,531,653 reads were mapped to library barcodes (Supplementary Table 12 ). For each library, paired-end reads were fused and filtered for quality (Phred $ 30). The resulting full-length reads were aligned against DIG10.1 using Enrich 38 . For single mutations having $7 counts in the original input library, a relative enrichment ratio between the input library and each selected library was calculated [23] [24] [25] . The effect of each amino acid substitution on binding, DE
